99 related articles for article (PubMed ID: 25872416)
1. CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese population.
Sun H; Pan Y; Wu R; Lv J; Chi X; Wang X; Tu Z; Zhong J; Sun B; Liu Y; Jiang J; Niu J
Liver Int; 2015 Mar; 35(3):786-94. PubMed ID: 25872416
[TBL] [Abstract][Full Text] [Related]
2. Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients.
Mei R; Chi X; Wu R; Xu H; Wang X; Gao X; Sun H; Lv J; Yu G; Kong F; Jiang J; Sun B; Zhong J; Pan Y; Niu J
J Gastroenterol Hepatol; 2016 Aug; 31(8):1489-97. PubMed ID: 26750805
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
4. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
[TBL] [Abstract][Full Text] [Related]
5. Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
Furusyo N; Ogawa E; Nakamuta M; Kajiwara E; Nomura H; Dohmen K; Takahashi K; Satoh T; Azuma K; Kawano A; Tanabe Y; Kotoh K; Shimoda S; Hayashi J;
J Hepatol; 2013 Aug; 59(2):205-12. PubMed ID: 23542346
[TBL] [Abstract][Full Text] [Related]
6. Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
Derbala MF; El Dweik NZ; Al Kaabi SR; Al-Marri AD; Pasic F; Bener AB; Shebl FM; Amer AM; Butt MT; Yakoob R; John A; Al Mohanadi M; Al Khinji MA
J Viral Hepat; 2008 Aug; 15(8):591-9. PubMed ID: 18482284
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.
Toyoda H; Kumada T; Tada T; Kawaguchi T; Murakami Y; Matsuda F
J Med Virol; 2011 Jul; 83(7):1203-11. PubMed ID: 21567424
[TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
Kowdley KV; Lawitz E; Crespo I; Hassanein T; Davis MN; DeMicco M; Bernstein DE; Afdhal N; Vierling JM; Gordon SC; Anderson JK; Hyland RH; Dvory-Sobol H; An D; Hindes RG; Albanis E; Symonds WT; Berrey MM; Nelson DR; Jacobson IM
Lancet; 2013 Jun; 381(9883):2100-7. PubMed ID: 23499440
[TBL] [Abstract][Full Text] [Related]
9. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients.
Chuang JY; Yang SS; Lu YT; Hsieh YY; Chen CY; Chang SC; Chang CS; Yeh HZ; Kao JH
Dig Liver Dis; 2009 Jun; 41(6):424-30. PubMed ID: 19004675
[TBL] [Abstract][Full Text] [Related]
10. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
[TBL] [Abstract][Full Text] [Related]
11. Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection.
Aghemo A; Rumi MG; Soffredini R; D'Ambrosio R; Ronchi G; Del Ninno E; Gallus S; Colombo M
Antivir Ther; 2006; 11(6):797-802. PubMed ID: 17310824
[TBL] [Abstract][Full Text] [Related]
12. Association of rs2111485 and rs1990760 Polymorphisms of Interferon Induced with Helicase C Domain 1 Gene with Hepatitis C Virus Clearance in Chinese Han Population.
Jiang W; Zhuo L; Wu X; Shen J; Ye X; Wang Y; Xia X; Chen H; Yu R; Yang S; Huang P
Viral Immunol; 2019 Oct; 32(8):341-347. PubMed ID: 31539314
[TBL] [Abstract][Full Text] [Related]
13. MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response.
Zupin L; Polesello V; Alberi G; Moratelli G; Crocè SL; Masutti F; Pozzato G; Crovella S; Segat L
Scand J Immunol; 2016 Jul; 84(1):61-9. PubMed ID: 27136459
[TBL] [Abstract][Full Text] [Related]
14. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
[TBL] [Abstract][Full Text] [Related]
15. A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients.
Xu Y; Huang P; Yue M; Su J; Chen H; Chen M; Wang J; Li J; Peng Z; Zhang Y; Yu R
J Hum Genet; 2016 Apr; 61(4):301-5. PubMed ID: 26632884
[TBL] [Abstract][Full Text] [Related]
16. The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.
Pei JP; Jiang LF; Ji XW; Xiao W; Deng XZ; Zhou ZX; Zhu DY; Ding WL; Zhang JH; Wang CJ; Jing K
Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1377-86. PubMed ID: 27230511
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in RIG-I-like receptor influences HCV clearance in Chinese Han population.
Wu X; Zang F; Liu M; Zhuo L; Wu J; Xia X; Feng Y; Yu R; Huang P; Yang S
Epidemiol Infect; 2019 Jan; 147():e195. PubMed ID: 31364528
[TBL] [Abstract][Full Text] [Related]
18. Association of CXCR2 genotype variations with HCV clearance in a Chinese population.
Zang F; Yue M; Zhuo L; Wu J; Liu M; Yao Y; Wang J; Feng Y; Xia X; Huang P; Yu R
Arch Virol; 2018 Oct; 163(10):2711-2718. PubMed ID: 29948377
[TBL] [Abstract][Full Text] [Related]
19. IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.
Origa R; Marceddu G; Danjou F; Perseu L; Satta S; Demartis FR; Piga A; Longo F; Lai ME; Vacquer S; Galanello R
Ann Hepatol; 2015; 14(3):389-95. PubMed ID: 25864220
[TBL] [Abstract][Full Text] [Related]
20. A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China.
Lei JH; Yang X; Xiao XQ; Chen Z; Peng F
BMC Gastroenterol; 2017 Mar; 17(1):42. PubMed ID: 28292275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
